News

ORSIF, fluoroscopy, interventional, health risks, awareness

A new non-profit association, the Organization for Occupational Radiation Safety in Interventional Fluoroscopy (ORSIF), was recently launched to generate awareness of the potential serious health...

expert consensus, SCAI, ACC, HFSA, STS, heart pumps, MCS devices

An expert consensus statement released by four leading cardiovascular societies provides new guidance on percutaneous mechanical circulatory support (MCS) devices for treatment of heart failure....

IMRIS, Visius iCT, Health Canada, licensing

IMRIS Inc. announced that Visius iCT, its ceiling-mounted intraoperative computed tomography scanner, has received Health Canada licensing allowing for sales and marketing in the country.

iFR Scout, pullback software, iFR Modality, fractional flow reserve, FFR

Royal Philips announced that Volcano, a Philips business, has received CE Mark for the iFR Scout pullback software. iFR Scout is a functional extension of its existing instant wave-Free Ratio...

The opening session speakers at the Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions will examine the current state of cardiovascular care and why it is...

hospital, stay, heart attack, angioplasty, study

Patients 65 or older discharged from the hospital as early as 48 hours after angioplasty following a major heart attack have similar outcomes as those who stay four to five days, provided...

Children's Hospital of Michigan, Ariana Smith, aortic aneurysm, 3-D printing

Seventeen-year-old Ariana Smith recently became the first patient at the Children's Hospital of Michigan, and the first in Michigan, to benefit from a revolutionary 3-D printed heart model to...

Medtronic plc announced the initiation of the SPYRAL HTN Global Clinical Trial Program, a phased clinical program studying renal denervation in uncontrolled hypertension. This announcement follows...

UHC has released the findings of a new study that evaluated the use of medical devices based on cost and quality outcomes. The goal of the study was to uncover several trends related to high-...

Corevalve, VIV, valve in valve, FDA

The U.S. Food and Drug Administration (FDA) expanded the approved use of the CoreValve self-expanding transcatheter aortic valve replacement (TAVR) system to treat certain patients who have...

The Medicines Company announced that the European Commission has granted marketing authorization for two acute care products – Kengrexal (cangrelor) and Raplixa (sealant powder). These approvals...

ticagrelor, AstraZeneca, FDA, crushing, option

AstraZeneca announced that the U.S. Food and Drug Administration (FDA) has approved a new administration option for acute coronary syndrome (ACS) patients who are unable to swallow ticagrelor (...

SCAI, 2015, Scientific Sessions, highlights, angiography

The Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions will take place May 6-9 in San Diego, California. SCAI 2015 will deliver updates affecting the invasive...

Edwards Lifesciences Corp. announced that chairman and CEO Michael A. Mussallem served as an invited expert panelist on behalf of the Advanced Medical Technology Association (AdvaMed) at the...

Adding the antiplatelet drug ticagrelor (Brilinta) to aspirin as long-term therapy after a heart attack significantly reduced the rate of subsequent death from cardiovascular causes, heart attack...

March 26, 2015 — Siemens Healthcare introduced a new angiography system and new cardiac ultrasound apps at the 2015 American College of Cardiology (ACC) annual meeting.  

Bendavia, heart attack, scarring, angioplasty, ACC, study

Patients who received the new drug Bendavia before undergoing angioplasty or stent implantation after a heart attack showed no significant reduction in scarring compared to patients given a...

Patients who experience the deadliest form of heart attack — ST-segment elevation myocardial infarction (STEMI) — and suffer from substantial narrowing in multiple heart arteries may benefit from...

BEST Trial

Despite the advent of a new generation of stents, patients with multiple narrowed arteries in the heart who received coronary artery bypass grafting fared better than those whose arteries were...

A novel therapy that would allow doctors to turn the body’s blood clotting ability off and on in a more controlled way was about as effective as established anticoagulants in patients undergoing...